PARTNER 1B
2010
Placement of Aortic Transcatheter Valves — cohort B (inoperable)
In 358 patients with severe AS deemed inoperable, transcatheter aortic-valve replacement reduced all-cause mortality at 1 year compared with medical therapy.
Result
Efficacy: All-cause mortalityHR 0.55
Below 1 favours transcatheter aortic-valve replacement, above 1 favours medical therapy.
- Absolute difference
- 20.0 points
The absolute difference is derived from the event rates.
- Subtopic
- TAVR
- Design
- RCT, 1 yr
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Cited in
- ESC 2025 VHDACC/AHA 2020 VHD
- Source
- Leon MB, et al. N Engl J Med. 2010;363(17):1597-1607.doi 10.1056/NEJMoa1008232
Discussion & critique
Vascular complications and stroke rates high in early TAVR; improved markedly in subsequent generations. Established TAVR for inoperable patients.